Birth Tissue Recovery Aug 2012 - Jun 2016
Co-Founder and Medical Director
Plakous Therapeutics Aug 2012 - Jun 2016
President and Medical Director
Applied Catheter Technologies Aug 2012 - Jun 2016
Medical Director
Lyndhurst Gynecologic Associates Aug 2012 - Jun 2016
Physician
Lyndhurst Gynecologic Assoc Aug 2012 - Jun 2016
Physician
Education:
University of Arkansas For Medical Sciences, College of Medicine 1982 - 1986
Doctor of Medicine, Doctorates
Hendrix College 1978 - 1982
Bachelors, Bachelor of Arts, Chemistry
Skills:
Medicine Clinical Research Healthcare Surgery Hospitals Public Health Medical Education Neuroscience Medical Devices Emergency Medicine Board Certified Biotechnology Healthcare Management Molecular Biology Emr Clinical Trials Cancer Life Sciences Pharmaceutical Industry Lifesciences Electronic Medical Record
Provided herein are multimodal barrier materials useful for preventing adhesions in a subject, which may include a collagen, a collagen deposition inhibitor and/or a chitosan.
Effects Of 17.Alpha.-Dihydroequilenin On Plasma Lipid And Lipoprotein, Glucose, Insulin Concentrations, Coronary Artery Vasomotor Function, And Reproductive Organ And Mammary Gland Proliferation In Atherosclerotic Mammals
Scott A. Washburn - Winston-Salem NC Thomas B. Clarkson - Clemmons NC Michael R. Adams - Clemmons NC Thomas C. Register - Clemmons NC J. Koudy Williams - Clemmons NC Janice D. Wagner - Kernersville NC J. Mark Cline - Winston-Salem NC Steven J. Adelman - Hatfield PA
Assignee:
Wake Forest University - Winston-Salem NC American Home Products Corporation - Madison NJ
International Classification:
A61K 3156
US Classification:
514182
Abstract:
The present invention relates to a method of using 17. alpha. -dihydroequilenin and metabolic conjugates thereof to prevent and reduce atherogenesis in males and females without causing endometrial proliferation in females and without producing feminizing changes in males. 17. alpha. -dihydroequilenin was evaluated for its effects on plasma lipid and lipoprotein, glucose, insulin concentrations, coronary artery vasomotor function, and reproductive organ and mammary gland proliferation in atherosclerotic mammals. 17. alpha. -dihydroequilenin was found to prevent endothelium-dependent vasoconstriction in males (p
Effects Of 17.Alpha.-Dihydroequilenin On Plasma Lipid And Lipoprotein, Glucose, Insulin Concentrations, Coronary Artery Vasomotor Function, And Reproductive Organ And Mammary Gland Proliferation In Atherosclerotic Mammals
Scott A. Washburn - Winston-Salem NC Thomas B. Clarkson - Clemmons NC Michael R. Adams - Clemmons NC Thomas C. Register - Clemmons NC J. Koudy Williams - Clemmons NC Janice D. Wagner - Kernersville NC J. Mark Cline - Winston-Salem NC Steven J. Adelman - Hatfield PA
Assignee:
Wake Forest University - Winston-Salem NC American Home Products Corporation - Madison NJ
International Classification:
A61K 3156
US Classification:
514182
Abstract:
The present invention relates to a method of using 17. alpha. -dihydroequilenin and metabolic conjugates thereof to prevent and reduce atherogenesis in males and females without causing endometrial proliferation in females and without producing feminizing changes in males. 17. alpha. -dihydroequilenin was evaluated for its effects on plasma lipid and lipoprotein, glucose, insulin concentrations, coronary artery vasomotor function, and reproductive organ and mammary gland proliferation in atherosclerotic mammals. 17. alpha. -dihydroequilenin was found to prevent endothelium-dependent vasoconstriction in males (p
Effects Of 17 .Alpha.-Dihydroequilenin On Plasma Lipid And Lipoprotein, Glucose, Insulin Concentrations, Coronary Artery Vasomotor Function, And Reproductive Organ And Mammary Gland Proliferation In Atherosclerotic Mammals
Scott A. Washburn - Winston-Salem NC Thomas B. Clarkson - Clemmons NC Michael R. Adams - Clemmons NC Thomas C. Register - Clemmons NC J. Koudy Williams - Clemmons NC Janice D. Wagner - Kernersville NC J. Mark Cline - Winston-Salem NC Steven J. Adelman - Hatfield PA
Assignee:
Wake Forest University - Winston-Salem NC American Home Products Corporation - Madison NJ
International Classification:
A61K31/56
US Classification:
514182
Abstract:
The present invention relates to a method of using 17. alpha. -dihydroequilenin and metabolic conjugates thereof to prevent and reduce atherogenesis in males and females without causing endometrial proliferation in females and without producing feminizing changes in males. 17. alpha. -dihydroequilenin was evaluated for its effects on plasma lipid and lipoprotein, glucose, insulin concentrations, coronary artery vasomotor function, and reproductive organ and mammary gland proliferation in atherosclerotic mammals. 17. alpha. -dihydroequilenin was found to prevent endothelium-dependent vasoconstriction in males (p
Method Of Preventing Neurodegeneration And Cognitive Dysfunction Using 17.Alpha.-Dihydroequilenin
Scott A. Washburn - Winston-Salem NC Carol Ann Shively - Winston-Salem NC
Assignee:
Wake Forest University - Winston-Salem NC
International Classification:
A61K 3156
US Classification:
514182
Abstract:
A method of using a steroidal compound, 17. alpha. -dihydroequilenin, to prevent and treat neurodegeneration and cognitive dysfunction in estrogen deficient females and to reduce the risk of Alzheimer's related dementia and other senile dementia related conditions in both males and females. The method comprises administering 17. alpha. -dihydroequilenin in a therapeutically effective amount to a mammal in need of increased cognitive function or to a mammal susceptible to estrogen deficiency-related neurodegeneration or to senile dementia of the Alzheimer's type.
Acellular Placental Therapies For Necrotizing Enterocolitis
A liquid formulation comprising an acellular extract of placental tissue and a solvent that may prevent the onset or reduce the symptoms of an intestinal condition in a subject when a therapeutically effective amount of the liquid formulation is delivered to a gastric system of the subject.
- Winston-Salem NC, US Scott A. Washburn - Pfafftown NC, US
International Classification:
C12N 5/073 A61K 35/50 A61K 38/55
Abstract:
Biological products are disclosed that have improved qualities relative to those that are currently available. Disclosed are compositions and methods for modulating cellular physiology and pathological processing using compositions that are derived from various placenta/villous chorion tissue.
Conditions of Pregnancy and Delivery Genital HPV Uterine Leiomyoma Abnormal Vaginal Bleeding Breast Disorders
Languages:
English Spanish
Description:
Dr. Washburn graduated from the University of Arkansas College of Medicine at Little Rock in 1986. He works in Winston-Salem, NC and 2 other locations and specializes in Obstetrics & Gynecology. Dr. Washburn is affiliated with Novant Health Forsyth Medical Center.